The 2017 European LeukemiaNet Genetic Risk Classification performs poorly in elderly Acute Myeloid Leukemia (AML) patients and should be refined to enable identification of patients requiring additional or alternative treatment (Alliance)
   Google Scholar   
Citation:
Blood vol 134 (Supplement 1) 2681
Meeting Instance:
ASH 2019
Year:
2019
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                                 
Networks:
CT063, LAPS-AL002, LAPS-MA036, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL, OH070   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-20202, CALGB-8461, CALGB-9665
Phases:
N/A
Keywords: